DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Key Insights The projected fair value for DENTSPLY SIRONA is US$57.77 based on 2 Stage Free Cash Flow to Equity...